In this episode, Deciphex CEO Donal O’Shea featured on AI Ireland's podcast to share his journey from academia to entrepreneurship, and how he’s leading the charge in transforming global pathology services with AI. Donal discusses the growing demand for diagnostics, the importance of international collaboration, and how AI can support, not replace, pathologists in delivering faster, more accurate diagnoses around the world.
Published on
April 10, 2025
Category
AI
Discover more
Patholytix
Corporate
Global
AI
AI Improving Drug Safety, Reducing Burden Generating better results during preclinical research
AI improves drug safety assessments so unsafe drugs and compounds never make it to human clinical trials. Leveraging AI to reduce Animal Burden.
Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus
By combining Deciphex’s unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI.
Diagnexia Analytix
Global
.png)
Deciphex Launches Diagnexia Analytix: AI-Driven Pathology Services for Translational Research and Development
Deciphex, the research pathology division of Deciphex, proudly announces the launch of Diagnexia Analytix, a comprehensive pathology service offering that integrates advanced analytics and AI-powered workflows with expert-led diagnostics to elevate study outcomes.
Podcast: AI's impact on Global Pathology with AI Ireland
In this episode, Deciphex CEO Donal O’Shea featured on AI Ireland's podcast to share his journey from academia to entrepreneurship, and how he’s leading the charge in transforming global pathology services with AI.
Diagnexia Launches Global Education and Outreach Program to Bridge Diagnostic Gaps in Resource-Limited Regions
Diagnexia, a leader in digital pathology services, proudly announces the launch of its Global Education and Outreach Program, a transformative initiative aimed at enhancing education, diagnostic access and healthcare outcomes in regions with limited pathology resources.
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus on advancing cutting-edge image management solutions